# Minimal Effective Volume 90% for Double-injection Costoclavicular Block

> **NCT07374952** · PHASE4 · NOT_YET_RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 60 (estimated)

## Conditions studied

- Brachial Plexus Blocks
- Lidocaine
- Nerve Block
- Dose Finding Study
- Costoclavicular Block

## Interventions

- **PROCEDURE:** Ultrasound-guided double-injection costoclavicular nerve block with same previous volume
- **PROCEDURE:** Ultrasound-guided double-injection costoclavicular nerve block with lower volume

## Key facts

- **NCT ID:** NCT07374952
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374952, "Minimal Effective Volume 90% for Double-injection Costoclavicular Block". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07374952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*